Urapidil

乌拉地尔

Report date: 2023/03/06 20:00:20
NME

Base Information

Drug NameUrapidil
Drug Alias Name呱胺甲尿啶UrapidilumEbrantil德天利喜定 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonists
TargetsAdrenergic receptors
Therapy Area/IndicationsDysuriaHypertensionStroke +[4] 
Global Approved IndicationsDysuriaHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryGermany
Original Approved DateN/A
Country/TerritoryGermanyEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesThe George Institute China
China Registration ClassN/A

Develop Information

Active CompaniesEverest Medicines (China) Co LtdEverest Medicines LtdThe George Institute China +[5] 
Inactive CompaniesN/A
Active IndicationsDysuriaHypertensionStroke +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeC02CA06
Related LinksWikipediaKEGG